First report of Acinetobacter pittii acute community-acquired pneumonia in an immunocompetent patient in France following a heat wave

BMC Infect Dis. 2024 Jan 2;24(1):35. doi: 10.1186/s12879-023-08945-y.

Abstract

Background: In recent years, Acinetobacter baumannii-calcoaceticus complex (ABC) infections have attracted attention, mainly because of the impact of carbapenem-resistant isolates in hospital-acquired infections. However, acute community-acquired ABC infections are not uncommon in warm and humid countries, where they are responsible for community-acquired infections with specific clinical features. To date, such infection has not been reported in France.

Case presentation: We report the case of a 55-year-old non-immunocompromised patient living in France with no known risk factors for community-acquired ABC infections who presented pneumonia with bloodstream infection due to wild-type A. pittii. The outcome was favorable after 7 days of antibiotic treatment with cefepime. We confirmed bacterial identification with whole-genome sequencing, and we examined the A. pitii core-genome phylogeny for genomic clusters.

Conclusions: This situation is uncommon in Europe and occurred after a heat wave in France with temperatures above 38 °C. Herein, we discuss the possibility that this pneumonia may be emerging in the current context of global warming.

Keywords: Acinetobacter calcoaceticus-baumannii complex; Acinetobacter pittii; Community-acquired pneumonia; Emerging infectious diseases; Global warming.

Publication types

  • Case Reports

MeSH terms

  • Acinetobacter Infections* / diagnosis
  • Acinetobacter Infections* / drug therapy
  • Acinetobacter Infections* / microbiology
  • Acinetobacter baumannii*
  • Acinetobacter* / genetics
  • Anti-Bacterial Agents / therapeutic use
  • Community-Acquired Infections* / diagnosis
  • Community-Acquired Infections* / drug therapy
  • France
  • Hot Temperature
  • Humans
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pneumonia* / diagnosis
  • Pneumonia* / drug therapy

Substances

  • Anti-Bacterial Agents

Supplementary concepts

  • Acinetobacter pittii